Taken together, these data suggest that elevated concentrations of FGF21/sTGFBR2 decrease diet-induced adiposity, improve metabolic dysfunction associated with obesity, and increase certain cortical bone variables, particularly when mice are at warmer environmental temperatures. The gene discussed is FGF21; the disease is Obesity.